Complete Filing Data
Alpha Star Acquisition Corp reported Stockholders Equity of -$2.97 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Alpha Star Acquisition Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$847.0K | $1.3M | $4.9M | $1.1M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$847.0K | $1.3M | $4.9M | $1.1M |
| General And Administrative Expense | $887.6K | $913.9K | $435.3K | $587.6K |
| Nonoperating Income Expense | $40.5K | $2.3M | $5.4M | $1.7M |
| Operating Income Loss | -$887.6K | -$913.9K | -$435.3K | -$587.6K |
| Net Income Loss Available To Common Stockholders Basic |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$173.6K | -$137.5K | -$200.8K | -$139.3K | $738.1K | $724.0K | $1.2M | $1.3M | $1.1M | $415.5K | -$15.3K | -$179.5K | -$800.00 | -$11.1K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$173.6K | -$137.5K | -$200.8K | -$139.3K | $738.1K | $724.0K | $1.2M | $1.3M | $1.1M | $415.5K | -$15.3K | -$179.5K | -$800.00 | -$11.1K |
| General And Administrative Expense | $179.6K | $142.4K | $223.8K | $459.3K | $110.5K | $238.9K | $104.6K | $91.0K | $121.3K | $105.0K | $178.7K | $188.9K | $800.00 | $11.1K |
| Nonoperating Income Expense | $6.0K | $4.9K | $23.0K | $320.1K | $848.6K | $963.0K | $1.3M | $1.4M | $1.3M | $520.5K | $163.3K | $9.4K | ||
| Operating Income Loss | -$179.6K | -$142.4K | -$223.8K | -$459.3K | -$110.5K | -$238.9K | -$104.6K | -$91.0K | -$121.3K | $105.0K | $178.7K | -$188.9K | -$800.00 | -$11.1K |
| Net Income Loss Available To Common Stockholders Basic | -$1.1M | $179.5K | $11.1K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | -$3.0M | -$3.6M | -$9.1M | -$4.5M | -$2.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $111.0K | $387.9K | |||
| Liabilities Current | $2.0M | $11.6M | $6.2M | $1.8M | $2.9M |
| Liabilities | $3.0M | $14.4M | $9.1M | $4.6M | $2.9M |
| Assets Current | $6.3K | $10.8M | $12.5K | $111.0K | $115.5M |
| Assets | $724.4K | $11.1M | $101.6M | $118.3M | $115.5M |
| Temporary Equity Carrying Amount Attributable To Parent | $718.1K | $292.5K | $101.6M | $118.2M | $115.0M |
| Retained Earnings Accumulated Deficit | -$11.2M | -$10.4M | -$9.1M | -$4.5M | -$2.4M |
| Liabilities And Stockholders Equity | $724.4K | $11.1M | $101.6M | $118.3M | $115.5M |
| Common Stock Value | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K |
| Accrued Liabilities Current | $590.8K | $350.2K | $220.4K | $199.9K | $53.0K |
| Liabilities Noncurrent | $950.0K | $2.9M | $2.9M | $2.9M | |
| Assets Noncurrent | $718.1K | $292.5K | $101.6M | $118.2M | |
| Assets Held In Trust Noncurrent | $718.1K | $292.5K | $101.6M | $118.2M | |
| Investment Of Cash In Trust Account | $630.0K | $4.1M | $1.5M | ||
| Marketable Securities Unrealized Gain Loss | $448.0K | $382.2K | |||
| Assets Held In Trust Current | $10.8M | $115.0M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$111.0K | -$276.9K | |||
| Deferred Underwriting Commissions Non Current | $950.0K | $2.9M | $2.9M | $2.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$276.9K | ||||
| Deferred Compensation Liability Current | $2.9M | ||||
| Cash Held In Escrow | $387.9K | ||||
| Cash Withdrawn From Trust Account To Redeem Public Shares | 26.1M | ||||
| Promissory Notes And Loan Payable To Sponsor | $1.4M | $394.5K | $5.8M | ||
| Redemption Liability Current | $10.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$4.5M | -$4.2M | -$3.9M | -$3.4M | -$9.8M | -$9.5M | -$8.0M | -$7.0M | -$5.8M | -$3.3M | -$2.8M | -$2.6M | $13.2K | $14.0K | $25.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $101.6K | $101.6K | $26.7K | $130.2K | $175.7K | $188.8K | $118.8K | $236.5K | ||||||||
| Liabilities Current | $1.8M | $1.6M | $1.1M | $648.2K | $7.1M | $6.8M | $8.2M | $7.2M | $5.9M | $3.4M | $3.0M | $2.9M | ||||
| Liabilities | $4.7M | $4.5M | $4.0M | $3.5M | $9.9M | $9.6M | $8.2M | $7.2M | $5.9M | $3.4M | $3.0M | $2.9M | ||||
| Assets Current | $179.3K | $261.5K | $40.8K | $25.1K | $48.8K | $66.4K | $99.5M | $123.4M | $120.7M | $116.2M | $115.4M | $115.3M | ||||
| Assets | $845.7K | $791.9K | $461.4K | $11.0M | $66.8M | $65.7M | $99.5M | $123.4M | $120.7M | $116.2M | $115.4M | $115.3M | ||||
| Temporary Equity Carrying Amount Attributable To Parent | $641.4K | $530.5K | $420.6K | $10.9M | $66.7M | $65.6M | $99.4M | $123.2M | $120.6M | $116.1M | $115.2M | $115.0M | ||||
| Retained Earnings Accumulated Deficit | -$10.9M | -$10.7M | -$10.6M | -$10.4M | -$9.8M | -$9.5M | -$8.0M | -$7.0M | -$5.8M | -$3.3M | -$2.8M | -$2.6M | ||||
| Liabilities And Stockholders Equity | $845.7K | $791.9K | $461.4K | $11.0M | $66.8M | $65.7M | $99.5M | $123.4M | $120.7M | $116.2M | $115.4M | $115.3M | ||||
| Common Stock Value | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | $3.2K | ||||
| Accrued Liabilities Current | $493.1K | $447.7K | $403.6K | $613.2K | $315.1K | $323.7K | $216.5K | $144.4K | $140.9K | $155.6K | $133.9K | $5.8K | ||||
| Liabilities Noncurrent | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | ||||||||||
| Assets Noncurrent | $666.4K | $530.5K | $420.6K | $11.0M | $66.7M | $65.7M | ||||||||||
| Assets Held In Trust Noncurrent | $666.4K | $530.5K | $420.6K | $11.0M | $66.7M | $65.7M | ||||||||||
| Investment Of Cash In Trust Account | $280.0K | $1.1M | ||||||||||||||
| Marketable Securities Unrealized Gain Loss | $286.0K | $500.2K | $461.1K | $221.5K | $83.3K | |||||||||||
| Assets Held In Trust Current | $99.4M | $123.2M | $120.6M | $118.2M | $116.1M | $115.2M | $115.0M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$84.3K | |||||||||||||||
| Deferred Underwriting Commissions Non Current | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$84.3K | -$199.1K | $236.5K | $325.0K | ||||||||||||
| Deferred Compensation Liability Current | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | |||||||||
| Cash Held In Escrow | $101.6K | $101.6K | $26.7K | $111.0K | $130.2K | $175.7K | $188.8K | |||||||||
| Cash Withdrawn From Trust Account To Redeem Public Shares | 10.8M | 37.2M | ||||||||||||||
| Promissory Notes And Loan Payable To Sponsor | $1.3M | $1.1M | $709.3K | |||||||||||||
| Redemption Liability Current | $10.8M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Increase Decrease In Accrued Liabilities | $240.6K | $129.8K | $20.5K | $146.9K |
| Net Cash Provided By Used In Operating Activities | -$651.8K | -$243.4K | -$235.9K | -$276.9K |
| Net Cash Provided By Used In Financing Activities | -$9.8M | -$92.5M | -$21.9M | $1.5M |
| Net Cash Provided By Used In Investing Activities | $10.4M | $92.7M | $22.0M | -$1.5M |
| Increase Decrease In Prepaid Expense | $4.8K | -$11.0K | $12.5K | -$142.2K |
| Increase Decrease In Due To Related Parties | $529.7K | $191.0K | $21.7K | |
| Increase Decrease In Investment Income Interest | $40.5K | $2.3M | $5.4M | $1.7M |
| Proceeds From Sponsor Loan | $4.2M | $1.5M | ||
| Proceeds From Related Party Debt | ||||
| Proceeds From Issuance Of Long Term Debt | $1.0M | $888.4K | $4.2M | |
| Proceeds From Issuance Of Common Stock | ||||
| Payments To Acquire Restricted Investments | $385.0K | $630.0K | ||
| Payments For Repurchase Of Common Stock | $10.8M | $93.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|
| Increase Decrease In Accrued Liabilities | $53.3K | $103.3K | -$59.0K | -$47.2K | $5.2K | |
| Net Cash Provided By Used In Operating Activities | -$209.8K | -$91.8K | -$199.1K | -$88.5K | ||
| Net Cash Provided By Used In Financing Activities | -$10.5M | -$36.9M | $1.1M | $325.0K | $325.0K | |
| Net Cash Provided By Used In Investing Activities | $10.7M | $36.9M | -$1.1M | |||
| Increase Decrease In Prepaid Expense | $39.3K | $53.9K | $52.5K | -$37.0K | ||
| Increase Decrease In Due To Related Parties | $189.5K | $141.0K | ||||
| Increase Decrease In Investment Income Interest | $23.0K | $963.0K | $1.3M | |||
| Proceeds From Sponsor Loan | $1.1M | |||||
| Proceeds From Related Party Debt | $280.0K | $1.1M | ||||
| Proceeds From Issuance Of Long Term Debt | $314.8K | $280.0K | ||||
| Proceeds From Issuance Of Common Stock | $25.0K | $25.0K | ||||
| Payments To Acquire Restricted Investments | $105.0K | $280.0K | ||||
| Payments For Repurchase Of Common Stock | $10.8M | $37.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Temporary Equity Shares Authorized | 22.7K | 22.7K | 9.1M | 11.5M | 11.5M |
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M |
| Common Stock Shares Outstanding | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M |
| Common Stock Shares Issued | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M |
| Temporary Equity Redemption Price Per Share | $31.68 | $12.91 | $11.21 | $10.28 | $10.00 |
| Basic And Diluted Net Loss Per Share Non Redeemable Common Stock | $-0.14 | ||||
| Basic And Diluted Weighted Average Shares Outstanding Non Redeemable Ordinary Shares | 3.2M | ||||
| Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Redemption | 11.5M | ||||
| Basic And Diluted Net Income Loss Per Share | |||||
| Basic And Diluted Net Loss Per Share | $0.14 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Temporary Equity Shares Authorized | 22.7K | 22.7K | 22.7K | 903.0K | 5.7M | 5.7M | 9.1M | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | |||
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |||
| Common Stock Shares Outstanding | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | |||
| Common Stock Shares Issued | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | |||
| Temporary Equity Redemption Price Per Share | $28.30 | $23.41 | $18.56 | $12.05 | $11.60 | $11.42 | $10.96 | $10.72 | $10.49 | $10.09 | $10.02 | ||||
| Basic And Diluted Net Loss Per Share Non Redeemable Common Stock | $-0.08 | $-0.08 | $-0.09 | $-0.03 | $-0.01 | $-0.01 | $0.00 | $0.00 | $0.00 | ||||||
| Basic And Diluted Weighted Average Shares Outstanding Non Redeemable Ordinary Shares | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 2.9M | 2.9M | 2.9M | ||||||
| Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Redemption | 9.6M | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | |||||||||
| Basic And Diluted Net Income Loss Per Share | $0.15 | $0.14 | $0.12 | $0.05 | $0.00 | $-0.01 | |||||||||
| Basic And Diluted Net Loss Per Share | $0.05 | $0.00 | $-0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Interest Earned And Unrealize Gain On Trust Account | -40.5K | -2.3M | -5.4M | -1.7M |
| Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Additional Funding For Business Combination Extension | -385.0K | -630.0K | -4.1M | -1.5M |
| Interest Income Operating | $4.9M | $1.3M | ||
| Prepaid Expense Current | $6.3K | $1.5K | $12.5K | |
| Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption | 425.5K | 2.9M | 9.5M | 3.2M |
| Other Operating Income Expense Net | $350.00 | $5.00 | ||
| Interest And Dividend Income Securities | $40.5K | $2.3M | $5.4M | |
| Loss From Operation Costs | ||||
| Escrow Deposit | $111.0K | |||
| Promissory Note Related Party | ||||
| Unrealized Gain In Trust Account | $382.2K | |||
| Interest Earned In Trust Account | $1.3M | |||
| Additional Paid In Capital | $8.3M | $6.8M | ||
| Redemption Of Public Shares | 93.4M | 26.1M | ||
| Adjustment For Amortization | $142.2K | |||
| Promissory Notes Sponsor | $1.5M | |||
| Subsequent Measurement Of Ordinary Shares Subject To Redemption Against Additional Paidincapital Apic And Accumulated Deficit | 3.2M | |||
| Proceeds Of Promissory Note From Sponsor | ||||
| Issuance Of Ordinary Shares To Sponsor | ||||
| Due To Related Parties |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Interest Earned And Unrealize Gain On Trust Account | -6.0K | -4.9K | -23.0K | -320.1K | -848.6K | -963.0K | -1.3M | -1.4M | -1.3M | -520.5K | ||||||||
| Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Additional Funding For Business Combination Extension | -105.0K | -105.0K | -105.0K | -105.0K | -210.0K | -210.0K | -906.3K | -1.2M | -1.1M | -383.3K | ||||||||
| Interest Income Operating | $677.0K | $916.7K | $929.4K | $807.3K | $299.0K | $80.0K | $9.4K | |||||||||||
| Prepaid Expense Current | $179.3K | $261.5K | $40.8K | $25.1K | $48.8K | $66.4K | $17.5K | $50.0K | $52.5K | $30.0K | $67.8K | $105.2K | $142.2K | |||||
| Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption | 128.0K | 1.2M | 2.4M | |||||||||||||||
| Other Operating Income Expense Net | $420.6K | $221.5K | $5.00 | |||||||||||||||
| Interest And Dividend Income Securities | $6.0K | $4.9K | $23.0K | $320.1K | $848.6K | $963.0K | $1.3M | $1.4M | ||||||||||
| Loss From Operation Costs | -$104.6K | -$91.0K | -$121.3K | -$105.0K | -$178.7K | -$188.9K | -$800.00 | -$11.1K | ||||||||||
| Escrow Deposit | ||||||||||||||||||
| Promissory Note Related Party | $3.9M | $2.7M | $1.5M | |||||||||||||||
| Unrealized Gain In Trust Account | $461.1K | |||||||||||||||||
| Interest Earned In Trust Account | $807.3K | $9.4K | ||||||||||||||||
| Additional Paid In Capital | $6.4M | $6.5M | $6.6M | $7.0M | ||||||||||||||
| Redemption Of Public Shares | 37.2M | |||||||||||||||||
| Adjustment For Amortization | ||||||||||||||||||
| Promissory Notes Sponsor | $35.0K | $6.2M | $6.0M | $5.8M | ||||||||||||||
| Subsequent Measurement Of Ordinary Shares Subject To Redemption Against Additional Paidincapital Apic And Accumulated Deficit | ||||||||||||||||||
| Proceeds Of Promissory Note From Sponsor | $300.0K | $300.0K | ||||||||||||||||
| Issuance Of Ordinary Shares To Sponsor | 25.0K | |||||||||||||||||
| Due To Related Parties | $212.7K | $212.7K | $162.7K | $21.7K |
Most recent annual filing with the SEC: March 20, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.